Drug Search Results
More Filters [+]

Carbimazole

Alternative Names: carbimazole
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Iodine Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Austria | Bangladesh | Cyprus | Denmark | Dominican Republic | Egypt | Finland | France | Greece | Hong Kong | Iceland | India | Indonesia | Ireland | Jordan | Korea | Malaysia | Malta | Morocco | Netherlands | New Zealand | Norway | Pakistan | Philippines | Saudi Arabia | Singapore | South Africa | Spain | Sri Lanka | Switzerland | Taiwan | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Newcastle-upon-Tyne Hospitals NHS Trust
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbimazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Graves Disease

Phase 3: Graves Disease|Hyperthyroidism

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChoPS

P3

Unknown status

Graves Disease|Hyperthyroidism

2018-03-01

ACTRN12615000362594

P4

Terminated

Graves Disease

2016-09-06

Recent News Events